|
1
|
Bar-Sela G, Epelbaum R and Schaffer M:
Curcumin as an anti-cancer agent: Review of the gap between basic
and clinical applications. Curr Med Chem. 17:190–197. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han SS, Chung ST, Robertson DA, Ranjan D
and Bondada S: Curcumin causes the growth arrest and apoptosis of B
cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa
B, and p53. Clin Immunol. 93:152–161. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dhillon N, Aggarwal BB, Newman RA, Wolff
RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock
R: Phase II trial of curcumin in patients with advanced pancreatic
cancer. Clin Cancer Res. 14:4491–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma RA, Euden SA, Platton SL, Cooke DN,
Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer
SM, et al: Phase I clinical trial of oral curcumin: Biomarkers of
systemic activity and compliance. Clin Cancer Res. 10:6847–6854.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carroll RE, Benya RV, Turgeon DK, Vareed
S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C,
Meyskens FL Jr and Brenner DE: Phase IIa clinical trial of curcumin
for the prevention of colorectal neoplasia. Cancer Prev Res
(Phila). 4:354–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goel A, Boland CR and Chauhan DP: Specific
inhibition of cyclooxygenase-2 (COX-2) expression by dietary
curcumin in HT-29 human colon cancer cells. Cancer Lett.
172:111–118. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Z, Zhang Y, Banerjee S, Li Y and
Sarkar FH: Notch-1 down-regulation by curcumin is associated with
the inhibition of cell growth and the induction of apoptosis in
pancreatic cancer cells. Cancer. 106:2503–2513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marin YE, Wall BA, Wang S, Namkoong J,
Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S and Ryu JH:
Curcumin downregulates the constitutive activity of NF-kappaB and
induces apoptosis in novel mouse melanoma cells. Melanoma Res.
17:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagamine M, Okumura T, Tanno S, Sawamukai
M, Motomura W, Takahashi N and Kohgo Y: PPAR gamma ligand-induced
apoptosis through a p53-dependent mechanism in human gastric cancer
cells. Cancer Sci. 94:338–343. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choudhuri T, Pal S, Agwarwal ML, Das T and
Sa G: Curcumin induces apoptosis in human breast cancer cells
through p53-dependent Bax induction. FEBS Lett. 512:334–340. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choudhuri T, Pal S, Das T and Sa G:
Curcumin selectively induces apoptosis in deregulated cyclin
D1-expressed cells at G2 phase of cell cycle in a p53-dependent
manner. J Biol Chem. 280:20059–20068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sintara K, Thong-Ngam D, Patumraj S and
Klaikeaw N: Curcumin attenuates gastric cancer induced by
N-methyl-N-nitrosourea and saturated sodium chloride in rats. J
Biomed Biotechnol. 2012:9153802012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai XZ, Wang J, Li XD, Wang GL, Liu FN,
Cheng MS and Li F: Curcumin suppresses proliferation and invasion
in human gastric cancer cells by downregulation of PAK1 activity
and cyclin D1 expression. Cancer Biol Ther. 8:1360–1368. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai XZ, Huang WY, Qiao Y, Du SY, Chen Y,
Chen D, Yu S, Che RC, Liu N and Jiang Y: Inhibitory effects of
curcumin on gastric cancer cells: A proteomic study of molecular
targets. Phytomedicine. 20:495–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang T, Zhang X, Xue W, Zhao S, Zhang X
and Pei J: Curcumin induced human gastric cancer BGC-823 cells
apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway.
Int J Mol Sci. 15:15754–15765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song G, Ming Y, Mao Y, Bao S and Ouyang G:
Osteopontin prevents curcumin-induced apoptosis and promotes
survival through Akt activation via alpha v beta 3 integrins in
human gastric cancer cells. Exp Biol Med (Maywood). 233:1537–1545.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanigawa S, Fujii M and Hou DX:
Stabilization of p53 is involved in quercetin-induced cell cycle
arrest and apoptosis in HepG2 cells. Biosci Biotechnol Biochem.
72:797–804. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xing CG, Zhu BS, Liu HH, et al: LY294002
induces p53-dependent apoptosis of SGC7901 gastric cancer cells.
Acta pharmacologica Sinica. 29:489–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Adriaenssens E, Dumont L, Lottin S, Bolle
D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J and Curgy
JJ: H19 overexpression in breast adenocarcinoma stromal cells is
associated with tumor values and steroid receptor status but
independent of p53 and Ki-67 expression. Am J Pathol.
153:1597–1607. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ariel I, Miao HQ, Ji XR, Schneider T, Roll
D, de Groot N, Hochberg A and Ayesh S: Imprinted H19 oncofetal RNA
is a candidate tumour marker for hepatocellular carcinoma. Mol
Pathol. 51:21–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li PF, Chen SC, Xia T, Jiang XM, Shao YF,
Xiao BX and Guo JM: Non-coding RNAs and gastric cancer. World J
Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song H, Sun W, Ye G, Ding X, Liu Z, Zhang
S, Xia T, Xiao B, Xi Y and Guo J: Long non-coding RNA expression
profile in human gastric cancer and its clinical significances. J
Transl Med. 11:2252013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kujundzić R Novak, Grbesa I, Ivkić M,
Katdare M and Gall-Troselj K: Curcumin downregulates H19 gene
transcription in tumor cells. J Cell Biochem. 104:1781–1792. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kakar SS and Roy D: Curcumin inhibits TPA
induced expression of c-fos, c-jun and c-myc proto-oncogenes
messenger RNAs in mouse skin. Cancer Lett. 87:85–89. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang EB, Han L, Yin DD, Kong R, De W and
Chen J: c-Myc-induced, long, noncoding H19 affects cell
proliferation and predicts a poor prognosis in patients with
gastric cancer. Med Oncol. 31:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barsyte-Lovejoy D, Lau SK, Boutros PC,
Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc
oncogene directly induces the H19 noncoding RNA by allele-specific
binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Geiler C, Andrade I and Greenwald D:
Exogenous c-Myc Blocks Differentiation and Improves Expansion of
Human Erythroblasts In vitro. International journal of stem cells.
7:153–157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie B, Zhou J, Shu G, Liu DC, Zhou J, Chen
J and Yuan L: Restoration of klotho gene expression induces
apoptosis and autophagy in gastric cancer cells: Tumor suppressive
role of klotho in gastric cancer. Cancer Cell Int. 13:182013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li N, Deng W, Ma J, et al: Prognostic
evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin
expression in gastric cancer. Med Oncol. 32:4332015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sorin V, Ohana P, Mizrahi A, et al:
Regional therapy with DTA-H19 vector suppresses growth of colon
adenocarcinoma metastases in the rat liver. International journal
of oncology. 39:1407–1412. 2011.PubMed/NCBI
|
|
40
|
Zang S, Liu T, Shi J and Qiao L: Curcumin:
A promising agent targeting cancer stem cells. Anticancer Agents
Med Chem. 14:787–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Field JK, Spandidos DA, Stell PM, Vaughan
ED, Evan GI and Moore JP: Elevated expression of the c-myc
oncoprotein correlates with poor prognosis in head and neck
squamous cell carcinoma. Oncogene. 4:1463–1468. 1989.PubMed/NCBI
|
|
43
|
Deming SL, Nass SJ, Dickson RB and Trock
BJ: C-myc amplification in breast cancer: A meta-analysis of its
occurrence and prognostic relevance. Br J Cancer. 83:1688–1695.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nair R, Roden DL, Teo WS, McFarland A,
Junankar S, Ye S, Nguyen A, Yang J, Nikolic I, Hui M, et al: c-Myc
and Her2 cooperate to drive a stem-like phenotype with poor
prognosis in breast cancer. Oncogene. 33:3992–4002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jang KY, Noh SJ, Lehwald N, Tao GZ,
Bellovin DI, Park HS, Moon WS, Felsher DW and Sylvester KG: SIRT1
and c-Myc promote liver tumor cell survival and predict poor
survival of human hepatocellular carcinomas. PLoS One.
7:e451192012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD,
Qin YY, Gong W and Quan ZW: Long non-coding RNA HOTAIR, a c-Myc
activated driver of malignancy, negatively regulates miRNA-130a in
gallbladder cancer. Mol Cancer. 13:1562014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hung CL, Wang LY, Yu YL, Chen HW,
Srivastava S, Petrovics G and Kung HJ: A long noncoding RNA
connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA.
111:18697–18702. 2014. View Article : Google Scholar : PubMed/NCBI
|
